All Stories

  1. Revisiting the Use of β-Blockers in Hypertension: Time for Action
  2. Cardiovascular disease outcomes: does physician’s sex matter?
  3. Unequal access to cardiovascular care: learning from European experience
  4. The Paradox of SMURF-less Outcomes and its Implication for Diabetes
  5. Microvascular Dysfunction in MINOCA: Still a Moving Target
  6. Sex Disparities in Ischemic Heart Disease Mortality Across United States: The Southern Burden of Excess Body Weight and Diet
  7. Changing clinical perspectives on sex and healthcare disparities in ischaemic heart disease
  8. Sex Disparities in Ischemic Heart Disease in South Asia
  9. Anticancer-Drug-Related Cardiotoxicity from Adjuvant Goserelin and Tamoxifen Therapy
  10. Sex Disparities in Ischemic Heart Disease Mortality in Europe
  11. Early coronary revascularization among ‘stable’ patients with non-ST-segment elevation acute coronary syndromes: the role of diabetes and age
  12. The European Society of Cardiology Working Group on Coronary Pathophysiology and Microcirculation
  13. Announcing The Lancet Regional Health-Europe commission on inequalities and disparities in cardiovascular health
  14. Coronary revascularization and sex differences in cardiovascular mortality after myocardial infarction in 12 high and middle-income European countries
  15. Net adverse clinical events with P2Y12 inhibitor therapy in older patients after percutaneous coronary interventions
  16. Traditional risk factors and premature acute coronary syndromes in South Eastern Europe: a multinational cohort study
  17. Combined Therapy with Anthracyclines and GnRH Analogues for Breast Cancer: Impact on Ischemic Heart Disease
  18. Clinical determinants of ischemic heart disease in Eastern Europe
  19. The ESC Working Group on Coronary Pathophysiology and Microcirculation
  20. Relationship Between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID‐19 and Preexisting Cardiovascular Disease
  21. Sex Differences in Heart Failure Following Acute Coronary Syndromes
  22. Sex differences and disparities in cardiovascular outcomes of COVID-19
  23. Micrornas As Potential Biomarkers In Coronary Artery Disease
  24. Mechanisms, therapeutic implications, and methodological challenges of gut microbiota and cardiovascular diseases: a position paper by the ESC Working Group on Coronary Pathophysiology and Microcirculation
  25. The Role of Vasospasm and Microcirculatory Dysfunction in Fluoropyrimidine-Induced Ischemic Heart Disease
  26. Statins for primary prevention among elderly men and women
  27. Gender Differences in Non-Obstructive Coronary Artery Disease
  28. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the Eu...
  29. Functional and structural adaptations of the coronary macro- and microvasculature to regular aerobic exercise by activation of physiological, cellular, and molecular mechanisms: ESC Working Group on Coronary Pathophysiology and Microcirculation positio...
  30. Concerns about the use of digoxin in acute coronary syndromes
  31. ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on ‘coronary microvascular dysfunction in cardiovascular disease’
  32. Vasospastic Angina and its Relationship with the Coronary Microcirculation
  33. Coronary No-Reflow Phenomenon in Clinical Practice
  34. Short term outcomes in the elderly patients with non-ST-elevation acute coronary syndromes undergoing early percutaneous coronary intervention: a report from the ISACS-TC registry
  35. Female sex as a biological variable: A review on younger patients with acute coronary syndrome
  36. Sex Differences in Outcomes After STEMI
  37. Prognostic implications of peripheral artery disease in coronary artery disease
  38. OBSOLETE: STEMI: Diagnosis
  39. OBSOLETE: STEMI: Prognosis
  40. OBSOLETE: STEMI: Management
  41. STEMI: Diagnosis
  42. STEMI: Management
  43. STEMI: Prognosis
  44. Cardiac involvement in myotonic dystrophy: The role of troponins and N-terminal pro B-type natriuretic peptide
  45. Acute Coronary Syndrome: The Risk to Young Women
  46. A Short History of Vasospastic Angina ∗
  47. Delayed Care and Mortality Among Women and Men With Myocardial Infarction
  48. Post cardiovascular surgery atrial fibrillation. Biomarkers determining prognosis.
  49. Position paper of the European Society of Cardiology–working group of coronary pathophysiology and microcirculation: obesity and heart disease
  50. ACUTE CORONARY SYNDROME: THE RISK TO BE YOUNG AND WOMEN
  51. Invasive versus conservative strategy in acute coronary syndromes: The paradox in women's outcomes
  52. Primary percutaneous coronary intervention in octogenarians
  53. The no-reflow phenomenon in the young and in the elderly
  54. Contemporary roles of registries in clinical cardiology: Insights from Western and Eastern European countries
  55. Association between comorbidities and absence of chest pain in acute coronary syndrome with in-hospital outcome
  56. Factors associated with use of percutaneous coronary intervention among elderly patients presenting with ST segment elevation acute myocardial infarction (STEMI): Results from the ISACS-TC registry
  57. Atypical Chest Pain in ACS: A Trap Especially for Women
  58. Barriers to Risk Stratification Accuracy in Ischemic Heart Disease in Women: The Role of Non-Obstructive Coronary Artery Disease
  59. Hypertension and Ischemic Heart Disease in Women
  60. Early Invasive Strategy for Unstable Angina: a New Meta-Analysis of Old Clinical Trials
  61. Big data: a new look at old problems
  62. DELAY TO HOSPITAL ADMISSION AND ACUTE CORONARY CARE IN THE ELDERLY AND IN THE VERY ELDERLY
  63. SEX-BASED DIFFERENCES IN SHORT TERM SURVIVAL AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION: THE ROLE OF SYSTEM DELAY
  64. Comparison of Early Versus Delayed Oral β Blockers in Acute Coronary Syndromes and Effect on Outcomes
  65. Persisting chest pain in nonobstructive coronary artery disease
  66. Reperfusion therapy for ST-elevation acute myocardial infarction in Eastern Europe: the ISACS-TC registry
  67. Unfractionated heparin–clopidogrel combination in ST-elevation myocardial infarction not receiving reperfusion therapy
  68. Vasotonic Angina as a Cause of Myocardial Ischemia in Women
  69. SEX-RELATED DIFFERENCES IN ACUTE CORONARY CARE AMONG PATIENTS WITH MYOCARDIAL INFARCTION: THE ROLE OF PRE-HOSPITAL DELAY
  70. DETECTING ACUTE STRESS DISORDERS IN PATIENTS WITH CORONARY ARTERY DISEASE: A PROGNOSTIC EVALUATION OF THE PHQ-9 IN ACUTE CORONARY CARE: FINDINGS FROM THE ISACS-TC STUDY
  71. EARLY VERSUS DELAYED USE OF BETA-BLOCKERS IN ACUTE CORONARY SYNDROMES: A LANDMARK ANALYSIS. FROM THE ISACS-TC STUDY
  72. PARADOXICAL SEX DIFFERENCE IN IN-HOSPITAL OUTCOME FOLLOWING AN ACUTE CORONARY SYNDROME MANAGED CONSERVATIVELY: RESULTS FROM THE ISACS-TC
  73. Exploring In-hospital Death from Myocardial Infarction in Eastern Europe: From the International Registry of Acute Coronary Syndromes in Transitional Countries (ISACS-TC); on the Behalf of the Working Group on Coronary Pathophysiology & Microcirculatio...
  74. Effects of Angiotensin-Converting Enzyme Inhibitors and Beta Blockers on Clinical Outcomes in Patients With and Without Coronary Artery Obstructions at Angiography (from a Register-Based Cohort Study on Acute Coronary Syndromes)
  75. ROUTINE PERCUTANEOUS CORONARY INTERVENTION VERSUS MEDICAL THERAPY IN CLINICAL PRACTICE: THE ISACS-TC REGISTRY
  76. Acute coronary syndrome in octogenarian patients: results from the international registry of acute coronary syndromes in transitional countries (ISACS-TC) registry
  77. Clinical profile of patients with no-reperfusion therapy in Bosnia and Herzegovina and Serbia
  78. Gender differences in case fatality rates of acute myocardial infarction in Serbia
  79. Hypertension and acute coronary syndromes in Romania: data from the ISACS-TC registry
  80. Endothelial Dysfunction and Long-Term Prognosis of Variant Angina
  81. Endothelial dysfunction versus early atherosclerosis: A study with high resolution imaging
  82. Presentation, management and outcomes of ischaemic heart disease in women
  83. UNFRACTIONED HEPARIN/CLOPIDOGREL INTERACTION IN PATIENTS WITH STEMI NOT UNDERGOING REPERFUSION